|
시장보고서
상품코드
1418431
세계 피부사상균성 조진균증 치료제 시장 보고서 - 동향, 예측, 경쟁 분석(-2030년)Dermatophytic Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
Lucintel
피부사상균성 조진균증 치료제의 동향과 예측
세계 피부사상균성 조진균증 치료제 시장은 2024년부터 2030년까지의 복합 연간 성장률(CAGR)이 4.5%를 나타낼 전망이며 2030년까지 추정 45억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진요인은 당뇨병 환자 증가, 노인 증가, 연구 증가, 매니큐어의 급속한 보급, 새로운 제네릭 의약품의 도입 급증에 의한 피부사상균성 조진균증 치료제의 발생률 증가입니다. 세계 피부사상균성 조진균증 치료제 치료제 시장의 미래는 처방약 시장과 시판약 시장에 기회가 있고 유망시되고 있습니다.
피부사상균성 조진균증 치료제 시장 인사이트
Lucintel의 예측은 Jubria의 채택이 증가하고 있기 때문에 예측 기간 동안 네일 페인트가 더 큰 부문으로 계속 될 것으로 보입니다.
이 시장에서 시클로필록스의 매출이 급증하고 있기 때문에 시판약이 계속 큰 부문이 될 것으로 보입니다.
북미는 피부사상균성 조진균증 치료제 치료의 처방 건수가 증가하고 있기 때문에 예측 기간 동안도 가장 규모가 큰 지역입니다.
FAQ
Q1. 시장 규모는?
A1. 세계 피부 사상균성 피부사상균성 조진균증 치료제 치료 시장은 2030년까지 예상 45억 달러에 이를 것으로 예상됩니다.
Q2. 시장의 성장 예측은?
A2. 세계 피부 사상균성 피부사상균성 조진균증 치료제 치료 시장은 2024년부터 2030년에 걸쳐 복합 연간 성장률(CAGR) 4.5%로 성장할 것으로 예측됩니다.
Q3. 시장 성장에 영향을 미치는 주요 촉진요인은?
A3.이 시장의 주요 촉진요인은 당뇨병의 빈도 증가, 노인 증가, 연구 증가, 매니큐어의 급속한 보급, 새로운 제약 의약품 도입의 급증으로 인한 손톱 곰팡이 감염의 발생률 증가 입니다.
Q4. 시장의 주요 부문은?
A4. 피부사상균성 조진균증 치료제 시장의 미래는 처방약 시장과 시판약 시장에 기회가 있어 유망합니다.
Q5. 시장의 주요 기업은?
A5. 피부사상균성 피부사상균성 조진균증 치료제 치료제 주요 기업은 다음과 같습니다.
- Bausch Health Companies
- Pfizer
- Galderma
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Cipla
- Kaken Pharmaceuticals
Q6. 앞으로 가장 큰 시장 부문은?
A6.Lucintel은 Jubria의 채택이 증가하고 있기 때문에 예측 기간 동안 네일 페인트가 더 큰 부문으로 계속 될 것으로 예측됩니다.
Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?
A7. 북미는 피부사상균성 조진균증 치료제 치료의 처방 건수가 증가함에 따라 예측 기간 동안에도 최대의 지역으로 남아 있습니다.
Q8. 보고서의 커스터마이즈는 가능?
A8. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.
목차
제1장 주요 요약
제2장 세계 피부사상균성 조진균증 치료제 치료 시장 : 시장 역학
- 소개, 배경, 분류
- 공급망
- 업계의 촉진요인과 과제
제3장 2018년-2030년 시장 동향과 예측 분석
- 거시경제 동향(2018년-2023년)과 예측(2024년-2030년)
- 세계 피부사상균성 조진균증 치료제 시장 동향(2018년-2023년)과 예측(2024년-2030년)
- 세계 피부사상균성 조진균증 치료제 치료 시장 - 제품 유형별
- 태블릿
- 네일 페인트
- 세계 피부사상균성 조진균증 치료제 치료 시장 - 투여 경로별
- 경구
- 국소
- 세계 피부사상균성 조진균증 치료제 치료 시장 - 유형별
- 소정
- 매장
- 세계 피부사상균성 조진균증 치료제 치료 시장 - 판매 채널별
- 병원 약국
- 소매 약국
- 온라인 채널
제4장 2018년-2030년 지역별 시장 동향과 예측 분석
- 지역별 세계 피부사상균성 조진균증 치료제 치료 시장
- 북미 피부사상균성 조진균증 치료제 시장
- 유럽 피부사상균성 조진균증 치료제 시장
- 아시아태평양 피부사상균증 손톱진균증 치료 시장
- 기타 지역의 피부사상균성 조진균증 치료제 치료 시장
제5장 경쟁 분석
- 제품 포트폴리오 분석
- 운영상의 통합
- Porter's Five Forces 분석
제6장 성장 기회와 전략적 분석
- 성장 기회 분석
- 제품 유형별 세계 피부사상균성 조진균증 치료제 치료 시장의 성장 기회
- 투여 경로별 세계 피부사상균성 조진균증 치료제 치료 시장의 성장 기회
- 유형별 세계 피부사상균성 조진균증 치료제 시장의 성장 기회
- 유통 채널별 세계 피부사상균성 조진균증 치료제 치료 시장의 성장 기회
- 지역별 세계 피부사상균성 조진균증 치료제 시장의 성장 기회
- 세계 피부사상균성 조진균증 치료제 치료 시장의 새로운 동향
- 전략적 분석
- 신제품 개발
- 세계 피부사상균성 조진균증 치료제 치료 시장의 능력 확대
- 세계 피부사상균성 조진균증 치료제 치료 시장에서의 합병, 인수, 합작 사업
- 인증 및 라이선싱
제7장 유력 기업의 기업 프로파일
- Bausch Health Companies
- Pfizer
- Galderma
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Cipla
- Kaken Pharmaceuticals
Dermatophytic Onychomycosis Treatment Trends and Forecast
The future of the global dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets. The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.
A more than 150-page report is developed to help in your business decisions.
Dermatophytic Onychomycosis Treatment by Segment
The study includes a forecast for the global dermatophytic onychomycosis treatment by product type, route of administration, type, distribution channel, and region.
Dermatophytic Onychomycosis Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Tablets
- Nail Paints
Dermatophytic Onychomycosis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
- Oral
- Topical
Dermatophytic Onychomycosis Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Prescribed
- Over-The-Counter
Dermatophytic Onychomycosis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Dermatophytic Onychomycosis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Dermatophytic Onychomycosis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dermatophytic onychomycosis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dermatophytic onychomycosis treatment companies profiled in this report include-
- Bausch Health Companies
- Pfizer
- Galderma
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Cipla
- Kaken Pharmaceuticals
Dermatophytic Onychomycosis Treatment Market Insights
Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.
Within this market, over-the-counter will remain the larger segment due to rapidly increasing ciclopirox sales.
North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.
Features of the Global Dermatophytic Onychomycosis Treatment Market
Market Size Estimates: Dermatophytic onychomycosis treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Dermatophytic onychomycosis treatment market size by various segments, such as by product type, route of administration, type, distribution channel, and region in terms of value ($B).
Regional Analysis: Dermatophytic onychomycosis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product type, route of administration, type, distribution channel, and regions for the dermatophytic onychomycosis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dermatophytic onychomycosis treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the dermatophytic onychomycosis treatment market size?
Answer: The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030.
Q2. What is the growth forecast for dermatophytic onychomycosis treatment market?
Answer: The global dermatophytic onychomycosis treatment market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the dermatophytic onychomycosis treatment market?
Answer: The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.
Q4. What are the major segments for dermatophytic onychomycosis treatment market?
Answer: The future of the dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets.
Q5. Who are the key dermatophytic onychomycosis treatment market companies?
Answer: Some of the key dermatophytic onychomycosis treatment companies are as follows.
- Bausch Health Companies
- Pfizer
- Galderma
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Cipla
- Kaken Pharmaceuticals
Q6. Which dermatophytic onychomycosis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.
Q7. In dermatophytic onychomycosis treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the dermatophytic onychomycosis treatment market by product type (tablets and nail paints), route of administration (oral and topical), type (prescribed and over-the-counter), distribution channel (hospital pharmacies, retail pharmacies, and online channels), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Dermatophytic Onychomycosis Treatment Market : Market Dynamics
- 2.1: Introduction, Background, and Classifications
- 2.2: Supply Chain
- 2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
- 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
- 3.2. Global Dermatophytic Onychomycosis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
- 3.3: Global Dermatophytic Onychomycosis Treatment Market by Product Type
- 3.3.1: Tablets
- 3.3.2: Nail Paints
- 3.4: Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
- 3.4.1: Oral
- 3.4.2: Topical
- 3.5: Global Dermatophytic Onychomycosis Treatment Market by Type
- 3.5.1: Prescribed
- 3.5.2: Over-the-Counter
- 3.6: Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
- 3.6.1: Hospital Pharmacies
- 3.6.2: Retail Pharmacies
- 3.6.3: Online Channels
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
- 4.1: Global Dermatophytic Onychomycosis Treatment Market by Region
- 4.2: North American Dermatophytic Onychomycosis Treatment Market
- 4.2.2: North American Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
- 4.3: European Dermatophytic Onychomycosis Treatment Market
- 4.3.1: European Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
- 4.3.2: European Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
- 4.4: APAC Dermatophytic Onychomycosis Treatment Market
- 4.4.1: APAC Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
- 4.4.2: APAC Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
- 4.5: ROW Dermatophytic Onychomycosis Treatment Market
- 4.5.1: ROW Dermatophytic Onychomycosis Treatment Market by Product Type: Tablets and Nail Paints
- 4.5.2: ROW Dermatophytic Onychomycosis Treatment Market by Type: Prescribed and Over-the-Counter
5. Competitor Analysis
- 5.1: Product Portfolio Analysis
- 5.2: Operational Integration
- 5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
- 6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Product Type
- 6.1.2: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Route of Administration
- 6.1.3: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Type
- 6.1.4: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel
- 6.1.5: Growth Opportunities for the Global Dermatophytic Onychomycosis Treatment Market by Region
- 6.2: Emerging Trends in the Global Dermatophytic Onychomycosis Treatment Market
- 6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Dermatophytic Onychomycosis Treatment Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dermatophytic Onychomycosis Treatment Market
- 6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
- 7.1: Bausch Health Companies
- 7.2: Pfizer
- 7.3: Galderma
- 7.4: GlaxoSmithKline
- 7.5: Janssen Pharmaceuticals
- 7.6: Cipla
- 7.7: Kaken Pharmaceuticals
